FDA panel issues mixed decision on quetiapine in depression and anxiety. JAMA : the journal of the American Medical Association [JAMA] Journal article

Title	FDA panel issues mixed decision on quetiapine in depression and anxiety.
Author(s)	Kuehn BM
Source	JAMA 2009 May 27; 301(20):2081-2.
MeSH	Antipsychotic Agents Anxiety Disorders Depressive Disorder, Major Dibenzothiazepines Drug Approval Humans United States United States Food and Drug Administration
Language	eng
Pub Type(s)	News
PubMed ID	19470978

Advertise on this site.